GMKBRegister for the upcoming International HundredK+ Cohorts Consortium (IHCC) webinar presented on Tuesday, June 28, 2022 at 8:00am ET/1:30pm UTC. Guest speaker Dr. Reza Malekzadeh will speak on “Using the IHCC to Prevent Premature Death Around the Globe.”
Dr. Malekzadeh is a Professor at the Digestive Disease Research Institute of Tehran in Iran. He founded the institute in 2000 and has since expanded it further. His main field of interest is digestive oncology and chronic disease with a special interest in prevention of NCD. He has also supervised and conducted several epidemiological and clinical studies and even established the first large-scale cohort study in the Middle East and North Africa (Golestan Cohort Study).
Dr. Malekzadeh is currently a member of 20 large-scale international collaborative studies. Since cardiovascular diseases (CVD), cancers, and other chronic diseases are the leading causes of morbidity and mortality in Iran, he is interested in investigating the environmental and genetic risk factors of chronic diseases as well as metabolic syndrome. For this reason, he has since started the Pars (Southern Iran) and Golestan (Northern Iran) Cohort Studies and several other studies including clinical trials, case control and ecologic studies, collecting detailed data and biological samples from cohort subjects and patients with cancer, CVD, chronic liver disease especially HBV, NAFLD/NASH.
He’s also established a pragmatic randomized control trial of healthy lifestyle and polypill for prevention of CVD and other NCD nested within the Golestan and pars cohort as well as the Persian Cohort, which includes all seven ethnicities of Iran with 200,000-sample size from 20 different provinces.
To learn more about the series, the upcoming webinar, our guest speaker, and to register for this event, please visit the IHCC Educational Webinar Series webpage.